Skip to main content
European Innovation Council
community
Story 24 June 2022
Public

BIO 2022: 20 European innovators paved the way for innovation and strategic business partnerships overseas

fvx16aqwyaaao7b.jpg
Eirini Sotiropoulou

On 13-16 June 2022, 20 pioneering EIC- funded SMEs, startups and scale-ups with breakthrough healthcare solutions met in San Diego, USA at BIO International Convention 2022, the leading medical biotech exhibition in the Americas. BIO brought together key international industry stakeholders and ensured attendees leave with precious insights and significant connections to unlock limitless future possibilities.

 

After two years of online programming, BIO conference has returned to San Diego Convention Center, attracting thousands of life sciences companies from across the globe to the annual event that sparked strategic collaborations and business deals that will transform the future of the industry. Through thought-provoking sessions, the interactive exhibit hall, countless networking opportunities and One-on-One-Partnering, attendees connected directly with European leaders and innovators. The agenda of the trade fair focused on critical topics such as business development, healthcare innovations and the dynamic potential of biotechnology sector.  

The European Pavilion hosted a diverse range of emerging technologies, including digital health products and sustainable biotech solutions that deliver a positive impact in the healthcare sector. During the business exhibition, the selected companies had the unique opportunity to engage with professionals around the North America region. 

pressnote.png

Among the key highlights stands out the European Night, an exclusive networking business reception organised by the European Innovation Council (EIC), EuropaBio, the Estonian Business and Innovation Agency, the Italian Trade Agency and the Switzerland Global Enterprise. The high-level event brought together more than 250 participants, including the best innovators and entrepreneurs from 10 European countries, who seized the opportunity to establish remarkable partnerships. The selected EIC-funded companies participated in 800+ business meetings with strategic stakeholders and generated 1000+ business contacts.

Over the course of the four-day tradeshow, the European presence was prevalent during the high-level sessions; under the Global Innovation Hub presentations, Dr. Cornelius Schmaltz, stressed out the fundamental role of the European Innovation Council in backing visionary entrepreneurs in Europe, while he also participated in a round table discussion with BIO and EuropaBio, focusing on new models for innovation funding.

pressnote_2.png

To find out more on the European SMEs that participated at BIO 2022, please click on the following link.

 

About EIC Overseas Trade Fairs Programme 2.0

The EIC Overseas Trade Fairs (OTF) Programme 2.0 supports EIC-funded SMEs, start-ups and scale-ups to develop their large-scale commercialisation strategy in foreign markets and leverage entrepreneurial opportunities at global innovation hubs, strengthening the European Union’s (EU) brand around the world. 

Building on the success of the Pilot OTF Programme, which took place between 2017-2018, the EIC OTF Programme 2.0 is running throughout 2022 and 2023, offering EIC beneficiaries the unprecedented opportunity to showcase their unconventional ideas at 15 international trade fairs in diverse sectors across EU and extra-EU markets.

Check the EIC OTF Programme 2.0 website for additional information and the list with the upcoming trade fairs. The EIC OTF Programme 2.0 continues the innovation journey at Florida International Medical Expo (July 2022) in Miami, USA, GITEX (October 2022) in Dubai, UAE and MEDICA (November 2022) in Düsseldorf, Germany. For stories, open calls and events, you may also visit the EIC Community Platform.

To follow the latest news and learn more about getting involved, please visit the EIC’s official social media accounts on Twitter and LinkedIn.

DISCLAIMER: This information is provided in the interest of knowledge sharing and should not be interpreted as the official view of the European Commission, or any other organisation.

Please log in to see comments and contribute